- South Africa
- Hong Kong
- New Zealand
- Czech Republic
- United Kingdom
Pfizer Clinical Research Units
What is Phase I Clinical Research?
The development of new medicines involves many stages and begins with several years of testing in a research laboratory. The next stage of development generally involves the study of potential new medicines in healthy populations. These early studies are called Phase I Clinical Research Studies. They will provide valuable information about how much and how often these potential new medicines should be given, and how people tolerate them.
Pfizer has three Phase I Clinical Research Units (CRU's) located around the world. With a CRU in New Haven, Connecticut; Brussels, Belgium and Singapore, the sun never sets on Pfizer's Clinical Research Units and opportunities to volunteer for a clinical research unit are available to almost everyone.
- Learn more about our New Haven CRU
- Learn more about our Brussels CRU
- Learn more about our Singapore CRU
Read Pfizer's commitment to conducting ethical research, ensuring the safety and privacy of patients and how we approach clinical trials.
Learn about the four phases of clinical trials and the importance of each in ensuring the safety and effectiveness of medical treatments.